Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Short physiotherapy program shows promise for palliative cancer patients

NCT ID NCT07654933

First seen Jun 21, 2026 · Last updated Jun 22, 2026 · Updated 1 time

Summary

This study tested whether a one-week physiotherapy program could improve movement, walking, and daily independence in 32 advanced cancer patients receiving palliative care. The program included exercises, mobility training, and breathing therapy tailored to each patient. Researchers measured changes in daily living skills, walking ability, and overall function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Jazan Health Cluster

    Jizan, 86611, Saudi Arabia

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

physiotherapy (individualized program including exercises, mobility training, and chest physiotherapy)

What this could lead to

If it works, this could show that short-term physiotherapy helps advanced cancer patients move better and feel more independent during palliative care.

What could go wrong

This is a small, single-hospital study with only 32 participants and no control group, so results may not apply widely. The benefits may be modest and short-lived.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.